"The Renewal of Cancer Immunotherapy" by top immunotherapy group & likely EMA reviewers: "they observed that patients who received DCVax-L survived for years after completing their vaccine doses, which could be due to an effective memory immune response"
Take a careful look at NOTE #7 : ALL are recognized top notch immuno oncology neuro surgeons affiliated with NWBO’s completed PH3 DCVAX L trial. https://www.mdpi.com/2076-393X/11/3/592
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.